NO305836B1 - Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler - Google Patents
Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidlerInfo
- Publication number
- NO305836B1 NO305836B1 NO960579A NO960579A NO305836B1 NO 305836 B1 NO305836 B1 NO 305836B1 NO 960579 A NO960579 A NO 960579A NO 960579 A NO960579 A NO 960579A NO 305836 B1 NO305836 B1 NO 305836B1
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- oxazolidin
- pharmaceuticals
- manufacture
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19504954A DE19504954A1 (de) | 1995-02-15 | 1995-02-15 | Adhäsionsrezeptor-Antagonisten |
Publications (3)
Publication Number | Publication Date |
---|---|
NO960579D0 NO960579D0 (no) | 1996-02-14 |
NO960579L NO960579L (no) | 1996-08-16 |
NO305836B1 true NO305836B1 (no) | 1999-08-02 |
Family
ID=7753962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO960579A NO305836B1 (no) | 1995-02-15 | 1996-02-14 | Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler |
Country Status (17)
Country | Link |
---|---|
US (1) | US5627197A (no) |
EP (1) | EP0727425A1 (no) |
JP (1) | JPH08253477A (no) |
KR (1) | KR960031457A (no) |
CN (1) | CN1061042C (no) |
AU (1) | AU705135B2 (no) |
CA (1) | CA2169433A1 (no) |
CZ (1) | CZ42996A3 (no) |
DE (1) | DE19504954A1 (no) |
HU (1) | HUP9600333A3 (no) |
NO (1) | NO305836B1 (no) |
PL (1) | PL183809B1 (no) |
RU (1) | RU2163602C2 (no) |
SK (1) | SK281449B6 (no) |
TW (1) | TW333528B (no) |
UA (1) | UA43848C2 (no) |
ZA (1) | ZA961159B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19516483A1 (de) * | 1995-05-05 | 1996-11-07 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
US5925635A (en) * | 1996-04-17 | 1999-07-20 | Dupont Pharmaceuticals Company | N-(amidinophenyl) cyclourea analogs as factor XA inhibitors |
WO1998046220A1 (en) * | 1997-04-14 | 1998-10-22 | Merck & Co., Inc. | Combination therapy for the prevention and treatment of osteoporosis |
US6017431A (en) * | 1997-07-17 | 2000-01-25 | Ppg Industries Ohio, Inc. | Cationic electrodepositable coating composition and bath thereof and process for retarding the growth of bacteria for such a bath |
DE19755268A1 (de) * | 1997-12-12 | 1999-06-17 | Merck Patent Gmbh | Benzamidinderivate |
AU2210400A (en) | 1998-12-23 | 2000-07-31 | G.D. Searle & Co. | Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
EP1147422A1 (en) | 1999-01-27 | 2001-10-24 | Pharmacia & Upjohn Company | Assays for modulators of "elongation factor p" activity |
DE10322469A1 (de) * | 2003-05-19 | 2004-12-16 | Bayer Healthcare Ag | Heterocyclische Verbindungen |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3856962A (en) * | 1973-07-10 | 1974-12-24 | R Alphin | Anti-inflammatory agents |
FR2631029B2 (fr) * | 1987-05-14 | 1991-04-05 | Cortial | Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmacologiquement compatibles |
DE3723797A1 (de) * | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
US5053393A (en) * | 1988-07-20 | 1991-10-01 | Monsanto Company | Novel platelet-aggregation inhibitor |
US5256812A (en) * | 1989-01-31 | 1993-10-26 | Hoffmann-La Roche Inc. | Carboxamides and sulfonamides |
US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
DE4005371A1 (de) * | 1990-02-21 | 1991-08-22 | Merck Patent Gmbh | Oxazolidinone |
DE4017211A1 (de) * | 1990-05-29 | 1991-12-05 | Merck Patent Gmbh | Oxazolidinone |
ES2134870T3 (es) * | 1993-05-01 | 1999-10-16 | Merck Patent Gmbh | Antagonistas del receptor de adhesion. |
DE4324393A1 (de) * | 1993-07-21 | 1995-01-26 | Merck Patent Gmbh | 4-Aryloxy- und 4-Arylthiopiperidinderivate |
-
1995
- 1995-02-15 DE DE19504954A patent/DE19504954A1/de not_active Withdrawn
-
1996
- 1996-01-05 TW TW085100077A patent/TW333528B/zh active
- 1996-02-07 EP EP96101746A patent/EP0727425A1/de not_active Withdrawn
- 1996-02-09 AU AU44462/96A patent/AU705135B2/en not_active Ceased
- 1996-02-12 SK SK185-96A patent/SK281449B6/sk unknown
- 1996-02-13 CA CA002169433A patent/CA2169433A1/en not_active Abandoned
- 1996-02-13 ZA ZA961159A patent/ZA961159B/xx unknown
- 1996-02-13 CN CN96102010A patent/CN1061042C/zh not_active Expired - Fee Related
- 1996-02-14 CZ CZ96429A patent/CZ42996A3/cs unknown
- 1996-02-14 PL PL96312812A patent/PL183809B1/pl unknown
- 1996-02-14 RU RU96102865/04A patent/RU2163602C2/ru active
- 1996-02-14 US US08/601,400 patent/US5627197A/en not_active Expired - Fee Related
- 1996-02-14 HU HU9600333A patent/HUP9600333A3/hu unknown
- 1996-02-14 NO NO960579A patent/NO305836B1/no not_active IP Right Cessation
- 1996-02-14 UA UA96020540A patent/UA43848C2/uk unknown
- 1996-02-15 JP JP8050757A patent/JPH08253477A/ja active Pending
- 1996-02-15 KR KR1019960003713A patent/KR960031457A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9600333A2 (en) | 1997-10-28 |
EP0727425A1 (de) | 1996-08-21 |
PL183809B1 (pl) | 2002-07-31 |
PL312812A1 (en) | 1996-08-19 |
HUP9600333A3 (en) | 1998-08-28 |
TW333528B (en) | 1998-06-11 |
UA43848C2 (uk) | 2002-01-15 |
DE19504954A1 (de) | 1996-08-22 |
HU9600333D0 (en) | 1996-04-29 |
AU705135B2 (en) | 1999-05-13 |
KR960031457A (ko) | 1996-09-17 |
NO960579L (no) | 1996-08-16 |
NO960579D0 (no) | 1996-02-14 |
CA2169433A1 (en) | 1996-08-16 |
CZ42996A3 (en) | 1996-09-11 |
SK18596A3 (en) | 1996-12-04 |
RU2163602C2 (ru) | 2001-02-27 |
CN1061042C (zh) | 2001-01-24 |
SK281449B6 (sk) | 2001-03-12 |
ZA961159B (en) | 1996-09-06 |
CN1134423A (zh) | 1996-10-30 |
AU4446296A (en) | 1996-08-22 |
JPH08253477A (ja) | 1996-10-01 |
US5627197A (en) | 1997-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO308107B1 (no) | Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel | |
NO944700D0 (no) | Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene | |
NO305906B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
NO965377D0 (no) | Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene | |
NO305903B1 (no) | Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater | |
NO306725B1 (no) | Ny krystallmodifikasjon av CDCH, fremgangsmate for fremstilling derav og farmasoytiske preparater inneholdende denne samt anvendelse av forbindelsen for fremstilling av legemidler | |
DK0807111T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstillingen heraf samt farmaceutiske sammensætninger indeholdende disse | |
NO903925D0 (no) | Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler. | |
AR027162A1 (es) | Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen | |
NO923434D0 (no) | 1,2-dihydro-2-oksopyridiner, fremgangsmaate for fremstilling derav, samt farmasoeytiske preparater som inneholder minst en slik forbindelse | |
NO973608D0 (no) | Nye farnesyl-transferaseinhibitorer, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene | |
FI943570A0 (fi) | 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita | |
NO980059L (no) | Nye oksazolidinonderivater, fremgangsmåte for fremstilling av dem, samt medikamenter som inneholder disse forbindelsene | |
ATE216238T1 (de) | Arzneimittel enthaltend lipidsenkende verbindungen | |
NO306113B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
NO305836B1 (no) | Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler | |
IS1885B (is) | Þíól afleiður með málmpeptíðasa letjandi virkni, aðferð til framleiðslu þeirra, lyfjaefnablöndur sem innihalda slíkt efnasamband, ásamt notkun á efnasamböndunum til framleiðslu á lyfjum | |
NO305793B1 (no) | 4-aminobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler | |
NO983540D0 (no) | Farmas°ytiske preparater av cilansetron som er stabilisert mot racemisering | |
NO305834B1 (no) | 4-merkaptobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler | |
DK469189D0 (da) | Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme | |
NO306993B1 (no) | Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler | |
NO903347L (no) | 14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler. | |
DE69318153T2 (de) | Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon | |
NO305560B1 (no) | Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN AUGUST 2003 |